None listed
Conditions
Interventions
Intervention1: Regenerated Cellulose Fibre (Bamboo): After taking a bath, gently pat or wipe the skin dry for 28 Days
Control Intervention1: Normal cotton turkey towels: Daily usage as required for
Sponsors
ENES TEXTILE MILLS
Eligibility
Inclusion criteria
Inclusion criteria: 1. Age group between 18 to 70 years, inclusive of equal proportion of male and female healthy participants. 2. Availability of participant for the entire study period and willing to adhere to protocol requirements as evidenced by the written ICF duly signed by the volunteer. 3. Participants with no evidence of life-threatening disease based on screening, medical history and physical examination within 28 days prior to the commencement of the study 4. Participants, who are willing to avoid sun bathing, swimming, prolonged sun exposure or artificial ultra-violet rays during the course of the study.
Exclusion criteria
Exclusion criteria: 1. Participants with history of allergies. 2. Participants who have fungal or bacterial skin infection, sunburned, chapped, or irritated skin or open wounds on test sites (Axilla, neck, hip and groin region). 3. Participants who have an underlying immunosuppressive condition
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1. A swab for bacterial and fungal analysis of the skin will be collected at baseline and again after 4 weeks of use, from one of the following areas: neck, axilla, hip, or groin. 2. The occurrence of any bacterial (including normal skin commensals and Staphylococcus) and fungal skin infections, as well as skin irritations, allergic reactions, prickly heat, rashes, and itching, will be monitored throughout the 4-week study period. 3. The user perceptions and feedback on softness, absorption of sweat, prevention of bad odor and comfortability will be assessed from baseline and up to 4 weeks. 4. Random samples of the towels (2 tests and 2 comparators) will be sent to the South India Textile Research Association (SITRA) for bacterial and fungal bioburden at the end of 4 weeks of study. Timepoint: Day 0 and end of week 4 | — |
Secondary
| Measure | Time frame |
|---|---|
| To monitor for any adverse events during the study period Timepoint: Day 0 and end of week 4 | — |
Countries
India
Contacts
Public ContactDr Gayathri Sivakumar
DK Elite Health Care Centre
Outcome results
None listed